game on

Sports tech festival coming to Houston this spring names 2 inaugural partners

Pokatok, which will take place in April 2024 in downtown Houston, named two new partners. Rendering courtesy of Pokatok

A sports-focused festival planning to premiere this spring has named two brand partnerships today.

Pokatok announced its teaming up with Beasley Esports and World Freestyle Football Association for the festival set to take place in downtown Houston on April 4 to 7, 2024.

“We’re building the world’s fair for sports which means showcasing as wide a variety of different sports as we can,” Lawson Gow, Pokatok co-founder, says in the news release, “and these two partners could not be more illustrative of the mix we are trying to achieve.”

Beasley Esports, which owns the Houston Outlaws, Team AXLE, and Juggernaut, will drive esports and gaming at the festival, as well as assist on programming, competitions, and more. The organization will also help coordinate activities — such as meet and greets and competitions — with esport professionals.

“I am most excited to see traditional sports and esports share the big stage — redefining the evolution in sports and technology and spotlighting all the excitement that lies ahead for sports enthusiasts — as it’s never been done before,” Lori Burgess, COO of Beasley ESport, says in the release.

The other newly announced partner, WFFA, will feature programming of its unique sport, freestyle football, which is defined in the release as a fusion of acrobatics, dance, music, and tricks with a football.

“The vibe and energy of what the Pokatok Festival will be, is perfectly in sync with the sport of Freestyle Football and what we do,” Dan Wood, co-founder of the WFFA, says in the release. “With the FIFA World Cup coming to Houston in 2026, it’s a great opportunity for everybody to already experience some other forms of Football related sporting entertainment.”

Pokatok was officially announced earlier this summer by its parent company Gow Companies, founded by Lawson Gow (who is the son of David Gow, InnovationMap's parent company's CEO). The festival will feature a sports tech expo, a film festival, speakers and panels, live music, pitch competitions, and more. The venue will be George R. Brown Convention Center, Discovery Green, and various nearby hotels. The full lineup of events has not yet been released, but interested parties can opt in for pre-sale information online.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted